4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-006377
Dake Benjamin T sold 10,283 shares at $18.17 ($186,829)
- Dake Benjamin T acquired 10,283 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 1 in the form | +2,412 | $1.74 | $4,197 | 2,412 | D |
| 2023-04-06 | Exercise or conversion : show line 2 in the form | +7,871 | $2.14 | $16,844 | 10,283 | D |
| 2023-04-06 | Sale : show line 3 in the form | −10,283 | $18.17 | $186,829 | 0 | D |
| Open-market sales · 10,283 sh · avg $18.17 · $186,829 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −905 | $1.74 | 2030-09-03 | 905 | 8,150 | D |
| 2023-04-06 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,507 | $1.74 | 2030-09-03 | 1,507 | 24,109 | D |
| 2023-04-06 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −1,019 | $2.14 | 2031-04-01 | 1,019 | 24,441 | D |
| 2023-04-06 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −6,852 | $2.14 | 2031-04-01 | 6,852 | 178,167 | D |
Loading xslF345X04/form4-04072023_060403.xml…